Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Array BioPharma Inc.
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2009
February 17th, 2009
Array BioPharma Inc. (NASDAQ: ARRY) reported financial results for the second quarter of the Company’s 2009 fiscal year ending December 31, 2008. FINANCIAL RESULTS Array reported revenue of $7.7 million for the second quarter of fiscal 2009, compared to revenue of $8.4 million for the same period in fiscal 2008. Array invested $23.7 million in research and development for the quarter to advance its eight wholly-owned drugs in clinical development and select discovery programs. This compares to $20.5 million invested in research and development during the same quarter of fiscal 2008. Array reported a net loss of $37.8 million, or ($0.79) per share, for the second quarter, compared to a net...
Source: Cancer Weekly (2009-02-17)
|
